NIH Shifts Meeting to Virtual with Time Adjustment
Published Date: 8/15/2025
Notice
Summary
The NIH Council of Councils meeting on September 11-12, 2025, has switched to fully virtual and moved to a new online location. The start and end times on September 12 have shifted slightly, and part of the meeting will be closed to the public. This update affects attendees and anyone following NIH decisions but doesn’t change any funding or deadlines.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
NIH Council meeting goes fully virtual
The NIH Council of Councils meeting on September 11–12, 2025 is now fully virtual. The meeting runs from September 11, 2025 at 10:00 a.m. through September 12, 2025 (start time on Sept. 12 changed to 10:00 a.m. and the end time changed to 2:15 p.m.), lists the location as National Institutes of Health, 1 Center Drive, Bethesda, MD 20892, and is partially closed to the public. This change does not alter any funding or deadlines.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10310 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting
The National Institute on Deafness and Other Communication Disorders is holding a private virtual meeting on July 20, 2026, to review grant applications. This meeting affects researchers seeking funding for projects related to hearing and communication disorders. No public access is allowed to protect sensitive information, and the decisions could impact future research funding.
2026-10231 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on June 25, 2026, to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants should note the date, as these reviews impact who gets money for their work.
2026-10175 — Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a private virtual meeting on June 9, 2026, to review grant applications about infectious diseases and immunology. This closed session protects sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as this review impacts funding decisions.
2026-09947 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting health science projects. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10022 — Submission for OMB Review; 30-Day Comment Request; Early Career Reviewer Program Online Application and Vetting System (Center for Scientific Review)
The NIH wants your thoughts on their Early Career Reviewer Program’s new online application and review system. This affects early career scientists applying to review research, making the process smoother and digital. You’ve got 30 days to share your feedback—no cost changes, just a smarter way to apply!
2026-10021 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to health and cancer research. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants and NIH staff are the main players, with no direct cost changes announced but important deadlines to keep in mind.
Previous / Next Documents
Previous: 2025-15556 — Revocation of Authorization of Emergency Use of In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability
The FDA is ending the emergency approval for LumiraDx’s COVID-19 test because the company asked them to. This means the test can no longer be used for quick COVID-19 diagnosis. If you use or sell this test, you’ll need to stop soon, but no extra costs or penalties are mentioned.
Next: 2025-15559 — Notice of OFAC Sanctions Actions
The U.S. Treasury’s OFAC just added new people to its blacklist, meaning their money and property in the U.S. are frozen. Americans can’t do business with these folks anymore, so watch out for these new restrictions. This move helps keep bad actors from using the U.S. financial system, and it’s effective immediately!